Skip to content

Formulations of Liposomal Local Anesthetics

Formulations of Liposomal Local Anesthetics for Dental Anesthesia

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01307969
Enrollment
40
Registered
2011-03-03
Start date
2007-02-28
Completion date
2007-06-30
Last updated
2011-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Underdosing of Local Anesthetics, Initial Encounter

Keywords

liposomes, ropivacaine, dental anesthesia, dentistry

Brief summary

This blinded cross-over study aim to evaluate the efficacy of liposome-encapsulated ropivacaine formulation for dental anesthesia.

Detailed description

This blinded cross-over study aim to evaluate the efficacy of liposome-encapsulated 0, 5% ropivacaine for dental anesthesia after maxillary infiltration.

Interventions

DRUGRopivacaine

1,8 mL of the local anesthetic formulations were injected at the apex of the maxillary right canine.

Sponsors

Fundação de Amparo à Pesquisa do Estado de São Paulo
CollaboratorOTHER_GOV
University of Campinas, Brazil
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 44 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy

Exclusion criteria

* Volunteers were free from cardiac, hepatic, renal, pulmonary, neurological, gastrointestinal and haematological diseases, psychiatric disorders and allergy to local anesthetics

Design outcomes

Primary

MeasureTime frame
After anesthetic injection the pulpal response was assessed by an electrical pulp tester.100 minutes

Secondary

MeasureTime frame
Duration of soft tissue anesthesia was measured as the time from beginning to end of lip and gingival numbness.240 minutes

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026